|
⚲
|
| Keyboard |
| Bma VIII LLC | |
|---|---|
| Firm | |
| Address | 345 Park Avenue New York, NY 10154 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM |
|---|---|---|---|---|---|
| BCP Biscuit Co-Invest LP | 021-503941 | Promoter | |||
| Emerald Blocked Consortium Aggregator LP | 021-482138 | Promoter | |||
| BCP Capstone Co-Invest LP | 021-481243 | Promoter | |||
| BCP 8 Emerald UTP Aggregator LP | 021-474244 | Promoter | |||
| Blackstone Emerald Co-Invest LP | 021-474247 | Promoter | |||
| Blackstone Aventine Co-Invest LP | 021-439703 | Promoter | 630.1 M | ||
| Blackstone Leo Co-Invest LP | 021-426953 | Promoter | |||
| Blackstone Mozart Co-Invest II LP | 021-407046 | Executive Officer | |||
| Blackstone Mozart Co-Invest LP | 021-407042 | Promoter | |||
| Blackstone Arches Co-Invest LP | 021-381989 | Promoter | |||
| Blackstone Power Play Co-Invest LP | 021-380869 | Promoter | |||
| Blackstone Management Partners LLC | |||||
| Blackstone Capital Partners VIII LP | 021-335593 | Promoter | 24.50 B of 24.50 B |
31.38 B | |
| Blackstone Capital Partners VIII Lux SCSP | 021-335595 | Promoter | 3,014.6 M | ||
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Medline Inc MDLN
Class A Common Stock
|
2026-03-10 | Other | 366,337 | ||
|
Medline Inc MDLN
Class A Common Stock
|
2026-03-10 | Sell | 8,241,723 | $40.51 | 333,872,199 |
|
Medline Inc MDLN
Class A Common Stock
|
2026-03-10 | Sell | 16,479,083 | $40.51 | 667,567,652 |
|
Medline Inc MDLN
Class A Common Stock
|
2026-03-10 | Sell | 1,886,636 | $40.51 | 76,427,624 |
|
Medline Inc MDLN
Class A Common Stock
|
2026-03-10 | Sell | 1,245,544 | $40.51 | 50,456,987 |
|
Medline Inc MDLN
Class B Common Stock
|
2026-03-05 | Other | 162,462 | ||
|
Medline Inc MDLN
Class A Common Stock
|
2026-03-05 | Conversion | 1,075,007 | ||
|
Medline Inc MDLN
Class B Common Stock
|
2026-03-05 | Other | 1,075,007 | ||
|
Medline Inc MDLN
Class A Common Stock
|
2026-03-05 | Conversion | 162,462 | ||
|
Medline Inc MDLN
Common Units of Medline Holdings, LP · derivative
|
2026-03-05 | Conversion | 1,075,007 | $0.00 | |
|
Medline Inc MDLN
Common Units of Medline Holdings, LP · derivative
|
2026-03-05 | Conversion | 162,462 | $0.00 | |
|
Medline Inc MDLN
Class B Common Stock
|
2026-03-04 | Other | 7,166,716 | ||
|
Medline Inc MDLN
Class A Common Stock
|
2026-03-04 | Conversion | 1,083,082 | ||
|
Medline Inc MDLN
Class A Common Stock
|
2026-03-04 | Conversion | 7,166,716 | ||
|
Medline Inc MDLN
Common Units of Medline Holdings, LP · derivative
|
2026-03-04 | Conversion | 7,166,716 | $0.00 | |
|
Medline Inc MDLN
Common Units of Medline Holdings, LP · derivative
|
2026-03-04 | Conversion | 1,083,082 | $0.00 | |
|
Medline Inc MDLN
Class B Common Stock
|
2026-03-04 | Other | 1,083,082 | ||
|
Legence Corp LGN
Class A Common Stock
|
2026-01-08 | Sell | 780,121 | $45.00 | 35,105,445 |
|
Legence Corp LGN
Class A Common Stock
|
2026-01-08 | Conversion | 780,121 | ||
|
Legence Corp LGN
Class B Units of Legence Holdings LLC · derivative
|
2026-01-08 | Conversion | 780,121 | ||
| showing 20 of 31 most recent transactions | |||||